A double-blind, placebo-controlled, fixed-dosage study comparing the efficacy and tolerability of paroxetine CR and citalopram to placebo in the treatment of Major Depressive Disorder with anxiety
Depressive Disorder, Major
Phase 4
The data from this study is provided in combined datasets containing data from other paroxetine studies. An annotated case report form is not available for this study. A link to and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
May 2014